Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562 |
Resumo: | Introduction: Syphilis is a slowly evolving infectious disease caused by a gram-negative bacterium in the group of spirochetes, exclusive to humans, called Treponema pallidum. In the fight against syphilis, an important tool is the laboratory analysis through products for in vitro diagnosis that allows the diagnosis of the disease. The effectiveness of these products is assessed against serological panels composed of true positive and negative samples. Objective: To reassess the reactivity of the 153 samples that make up the positive serological panel for syphilis at the Laboratory of Blood and Blood Products (LSH) of the National Institute for Quality Control in Health (INCQS). Method: Revalidation of the serological panel for syphilis through retrospective analysis of LSH laboratory data from 2011 to 2015, meeting the positivity criteria in 5 different methodologies and sample volume ≥ 10 mL. Results: Of the 172 initial samples, 153 had stock volume ≥ 10 mL. In the proposed period, 46 syphilis diagnosis products were identified with a satisfactory report, comprising 5 different methodologies. The analytical results of the 153 samples belonging to the positive panel were analyzed in the protocols for recording the results of these products. After re-evaluating the reactivity of the 153 samples from the positive panel 130, they were revalidated as positive while 23 were considered to be indeterminate. Conclusions: The positive panel for revalidated syphilis will remain an essential instrument in the previous analysis for the purpose of regularizing kits for diagnosing the disease. |
id |
FIOCRUZ-9_a7e4e7b6fcf30e72db627017df4138ff |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/1562 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosisRevalidação do painel sorológico positivo para sífilis – uma ferramenta no controle da qualidade de kits para diagnóstico da sífilisSífilis; Painel Sorológico; Controle de QualidadeIntroduction: Syphilis is a slowly evolving infectious disease caused by a gram-negative bacterium in the group of spirochetes, exclusive to humans, called Treponema pallidum. In the fight against syphilis, an important tool is the laboratory analysis through products for in vitro diagnosis that allows the diagnosis of the disease. The effectiveness of these products is assessed against serological panels composed of true positive and negative samples. Objective: To reassess the reactivity of the 153 samples that make up the positive serological panel for syphilis at the Laboratory of Blood and Blood Products (LSH) of the National Institute for Quality Control in Health (INCQS). Method: Revalidation of the serological panel for syphilis through retrospective analysis of LSH laboratory data from 2011 to 2015, meeting the positivity criteria in 5 different methodologies and sample volume ≥ 10 mL. Results: Of the 172 initial samples, 153 had stock volume ≥ 10 mL. In the proposed period, 46 syphilis diagnosis products were identified with a satisfactory report, comprising 5 different methodologies. The analytical results of the 153 samples belonging to the positive panel were analyzed in the protocols for recording the results of these products. After re-evaluating the reactivity of the 153 samples from the positive panel 130, they were revalidated as positive while 23 were considered to be indeterminate. Conclusions: The positive panel for revalidated syphilis will remain an essential instrument in the previous analysis for the purpose of regularizing kits for diagnosing the disease.Introdução: A sífilis é uma doença infecciosa de evolução lenta causada por uma bactéria Gramnegativa do grupo das espiroquetas, exclusiva do ser humano, chamada Treponema pallidum. No combate da sífilis, uma importante ferramenta é a análise laboratorial através de produtos para diagnóstico in vitro que permite o diagnóstico da doença. A eficácia destes produtos é avaliada frente a painéis sorológicos compostos por amostras verdadeiro positivas e negativas. Objetivo: Reavaliar a reatividade das 153 amostras que constituem o painel sorológico positivo para sífilis do Laboratório de Sangue e Hemoderivados (LSH) do Instituto Nacional de Controle de Qualidade em Saúde (INCQS). Método: Revalidação do painel sorológico para sífilis através de análise retrospectiva de dados laboratoriais do LSH do período de 2011 a 2015 atendendo aos critérios de positividade em cinco metodologias diferentes e volume de amostra ≥ 10 mL. Resultados: Das 172 amostras iniciais, 153 apresentaram volume de estoque ≥ 10 mL. No período proposto foram identificados 46 produtos para diagnóstico da sífilis com laudo satisfatório compreendendo cinco metodologias diferentes. Os resultados analíticos das 153 amostras pertencentes ao painel positivo foram analisados nos protocolos de registro de resultados destes produtos. Após a reavaliação da reatividade das 153 amostras do painel positivo, 130 foram revalidadas como positivas enquanto 23 foram consideradas como indeterminadas. Conclusões: O painel positivo para sífilis revalidado permanecerá sendo instrumento essencial na análise prévia para fins de regularização dos kits para diagnóstico da doença.Instituto Nacional de Controle de Qualidade em Saúde2020-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562Health Surveillance under Debate: Society, Science & Technology ; Vol. 8 No. 4 (2020): November - Monitoramento & Avaliação em Vigilância Sanitária; 129-133Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 8 Núm. 4 (2020): Noviembre - Monitoramento & Avaliação em Vigilância Sanitária; 129-133Vigil Sanit Debate, Rio de Janeiro; v. 8 n. 4 (2020): Novembro - Monitoramento & Avaliação em Vigilância Sanitária; 129-1332317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1268https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1307Copyright (c) 2020 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by/3.0/deed.pt_BRinfo:eu-repo/semantics/openAccessCustódio Deslandes do Passo, Danielle Coelho Adati, Marisa Copello Vigo, Danielle da Silva Ribeiro, Álvaro Machado Passo, Roberto Pereira da Silva Zamith, Helena 2023-06-27T15:13:00Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1562Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:13Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis Revalidação do painel sorológico positivo para sífilis – uma ferramenta no controle da qualidade de kits para diagnóstico da sífilis |
title |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis |
spellingShingle |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis Custódio Deslandes do Passo, Danielle Sífilis; Painel Sorológico; Controle de Qualidade |
title_short |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis |
title_full |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis |
title_fullStr |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis |
title_full_unstemmed |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis |
title_sort |
Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis |
author |
Custódio Deslandes do Passo, Danielle |
author_facet |
Custódio Deslandes do Passo, Danielle Coelho Adati, Marisa Copello Vigo, Danielle da Silva Ribeiro, Álvaro Machado Passo, Roberto Pereira da Silva Zamith, Helena |
author_role |
author |
author2 |
Coelho Adati, Marisa Copello Vigo, Danielle da Silva Ribeiro, Álvaro Machado Passo, Roberto Pereira da Silva Zamith, Helena |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Custódio Deslandes do Passo, Danielle Coelho Adati, Marisa Copello Vigo, Danielle da Silva Ribeiro, Álvaro Machado Passo, Roberto Pereira da Silva Zamith, Helena |
dc.subject.por.fl_str_mv |
Sífilis; Painel Sorológico; Controle de Qualidade |
topic |
Sífilis; Painel Sorológico; Controle de Qualidade |
description |
Introduction: Syphilis is a slowly evolving infectious disease caused by a gram-negative bacterium in the group of spirochetes, exclusive to humans, called Treponema pallidum. In the fight against syphilis, an important tool is the laboratory analysis through products for in vitro diagnosis that allows the diagnosis of the disease. The effectiveness of these products is assessed against serological panels composed of true positive and negative samples. Objective: To reassess the reactivity of the 153 samples that make up the positive serological panel for syphilis at the Laboratory of Blood and Blood Products (LSH) of the National Institute for Quality Control in Health (INCQS). Method: Revalidation of the serological panel for syphilis through retrospective analysis of LSH laboratory data from 2011 to 2015, meeting the positivity criteria in 5 different methodologies and sample volume ≥ 10 mL. Results: Of the 172 initial samples, 153 had stock volume ≥ 10 mL. In the proposed period, 46 syphilis diagnosis products were identified with a satisfactory report, comprising 5 different methodologies. The analytical results of the 153 samples belonging to the positive panel were analyzed in the protocols for recording the results of these products. After re-evaluating the reactivity of the 153 samples from the positive panel 130, they were revalidated as positive while 23 were considered to be indeterminate. Conclusions: The positive panel for revalidated syphilis will remain an essential instrument in the previous analysis for the purpose of regularizing kits for diagnosing the disease. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-11-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1268 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1307 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/3.0/deed.pt_BR info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/3.0/deed.pt_BR |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 8 No. 4 (2020): November - Monitoramento & Avaliação em Vigilância Sanitária; 129-133 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 8 Núm. 4 (2020): Noviembre - Monitoramento & Avaliação em Vigilância Sanitária; 129-133 Vigil Sanit Debate, Rio de Janeiro; v. 8 n. 4 (2020): Novembro - Monitoramento & Avaliação em Vigilância Sanitária; 129-133 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042045941972992 |